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Maternal immunization is an effective strategy to protect pregnant women and their infants
from vaccine-preventable diseases. Despite the recommendation of maternal influenza and
more recently pertussis immunization in Australia, uptake of these vaccines has been sub-
optimal. A midwife delivered immunization program for pregnant women at the Women’s
and Children’s Hospital in South Australia commenced in April 2015. Monitoring the uptake
of the current funded vaccine programs for pregnant women is limited. The study aimed to
estimate maternal vaccine uptake and assess factors associated with influenza and pertus-
sis vaccine uptake among pregnant women.
Methods
This prospective study was undertaken between November 2014 and July 2016 at the
Women’s and Children’s Hospital. Following consent, demographic details and vaccination
history for South Australian pregnant women who attended the antenatal clinic were col-
lected. A standardised self-reported survey was completed during pregnancy with a follow
up telephone interview at 8–10 weeks post-delivery.
Results
205 women consented and completed the self-reported survey. Of the 180 pregnant women
who completed the study, 76% and 81% received maternal influenza and pertussis vaccines
respectively. The adjusted odds of women receiving maternal vaccines during pregnancy
were significantly higher for women delivering after the implementation of the midwife deliv-
ered program compared with women who delivered babies prior to the program for both per-
tussis vaccination (AOR 21.17, 95% CI 6.14–72.95; p<0.001) and influenza vaccination
(AOR 5.95, 95% CI 2.13–16.61, p<0.001). Women receiving a recommendation from a
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health care provider and first time mothers were significantly more likely to receive influenza
vaccination during pregnancy.
Conclusions
High uptake of influenza and pertussis vaccines during pregnancy can be attained with
health care provider recommendation and inclusion of maternal immunization as part of
standard antenatal care. A midwife delivered maternal immunization program is a promising
approach to improve maternal vaccine uptake by pregnant women.
Introduction
Pregnant women are at increased risk of morbidity and death from influenza infection during
seasonal and pandemic influenza outbreaks [1–3]. This was particularly evident during the
2009 ‘H1N1’ influenza pandemic outbreak in Australia, in which the admission rate of preg-
nant women to an intensive care unit following infection with influenza was significantly
higher compared to non-pregnant adults [4, 5]. Infants born to women affected by influenza
during pregnancy are at increased risk of adverse birth outcomes such as preterm birth and
low birthweight [6]. Similarily, Bordetella pertussis infections can also pose high risk to infants
prior to their receipt of a complete primary course of pertussis immunization [7,8].
Immunization of pregnant women with influenza and pertussis has now been shown to be
effective in not only protecting the mother but also the fetus /newborn via transfer of transpla-
cental antibodies [9, 10] and through breastfeeding [11]. Maternal pertussis vaccination at
least 7 days before delivery can prevent up to 91% of pertussis disease in infants under 3
months of age [12]. Similarly, influenza vaccination during pregnancy can prevent up to 91%
of influenza related hospital admissions in infants under 6 months of age [13] and has been
shown to reduce influenza infections in pregnant women [14]. The safety of maternal influ-
enza and pertussis immunization is well established, with no reports of serious adverse compli-
cations to the unborn infant and pregnant women [15, 16]. Concomitant influenza and
pertussis vaccination will occur in pregnancies that overlap with the influenza season, with the
potential for different responses compared to separate adminsation of the vaccines in pregnant
women [17]. However, a study evaluating the safety of co-administering pertussis-containing
vaccine (Tdap) and influenza vaccines in pregnant women has not found an increased risk of
adverse events [18].
The Australian Immunisation Handbook was updated in March 2015 to recommend per-
tussis-containing vaccine (Tdap) for all pregnant women during the third trimester of each
pregnancy [19]. State government funded pertussis vaccination programs for pregnant women
were introduced progressively between August 2014 and June 2015 in all Australian states and
territories [20]. All Australian states provide pertussis vaccine for pregnant women via general
practitioners and hospital antenatal clinics, local councils, community health care centres, and
obstetricians. In South Australia, the funded vaccine was introduced from April 2015 and
accompanied with a large state-wide promotional campaign targeting health professionals and
pregnant women [20]. Influenza immunization for pregnant women has been supplied free of
charge and recommended at any time during pregnancy in Australia through the National
Immunization Program since 2010 [19]. Additionally, a midwife delivered maternal immuni-
zation program for influenza and pertussis vaccine was introduced in the antenatal clinic at
the Women’s and Children’s Hospital in South Australia (WCH) from April 2015. This
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program enables registered midwives to administer maternal influenza and pertussis vaccina-
tion using a standing medication order, without the need for a prescription from a medical
doctor [19].
Despite the recommendation of maternal influenza and more recently pertussis vaccina-
tions in Australia, uptake of the recommended vaccines has historically been poor. Maternal
influenza vaccine uptake in Australia has been estimated to range from about 7% to 40% [21–
26]. However, these estimates are usually derived from relatively small sample studies. There
are no published data on national maternal pertussis vaccine coverage in Australia. It is impor-
tant to monitor and evaluate the impact of government funded pertussis vaccination programs
for pregnant women and determine strategies to maximize uptake of vaccination for this pop-
ulation group. The primary objective of this study was to identify factors associated with the
uptake of pertussis and influenza vaccines during pregnancy and to determine the uptake of
influenza and pertussis vaccines among pregnant women in South Australia.
Materials and methods
Study population and design
This observational prospective study was undertaken between Nov-2014 and Jun-2016 at the
WCH (a major tertiary maternity hospital in South Australia with an annual birth cohort of
approximately 5000). Participation involved answering 26 questions about vaccination for pro-
tection against influenza and pertussis. A total of 300 pregnant women were approached and
invited to participate in this research study. Participation in the survey was voluntary. A
research nurse/medical officer discussed the study with the participants prior to obtaining
written informed consent
Eligibility criteria
Pregnant women were eligible to participate if they were aged 18 years or over at the time of
enrolment and had sufficient understanding of the English language. Pregnant women were
eligible to partake in this study regardless of their gestational stage or expected delivery date.
Data collection instrument
A standardised self-report questionnaire was designed to collect socio-demographic details
and information on awareness and uptake of the recommended maternal influenza and per-
tussis immunizations among pregnant women. A follow up telephone interview were con-
ducted 8–10 weeks post-delivery. Participants were classified as ‘lost to follow- up’ and
omitted from the analysis, if incorrect contact details were provided, if they refused further
participation, or did not answer six phone call attempts at different times and on different
days. The follow up telephone interview included questions to confirm whether they received
influenza and/or pertussis vaccination during their pregnancy, a date and location, and if not
during pregnancy, whether they had received influenza or pertussis vaccine post birth of their
baby (See supplement). Delivery date of the woman was used to compare maternal influenza
and pertussis immunization coverage prior to and following the implementation of the mid-
wife delivered maternal immunization program. The midwife vaccine delivery program
equipped midwives with knowledge and skills to engage with pregnant women on the topic of
maternal immunizations and administer pertussis and influenza immunizations to pregnant
women [27].
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Statistical analysis
The sample size was calculated assuming 55% of pertussis vaccine uptake during pregnancy
based on a self-reported survey (FluMum cohort study) [28] in 2015 collected over a three
month period at the Women’s and Children’s Hospital in South Australia. For this study, an
expected sample size of 200 participants enabled the uptake of pertussis vaccination amongst
pregnant women to be estimated and to determine predictors of maternal influenza and per-
tussis vaccination uptake with a ±5% precision at a 95% confidence level.
Survey data were analysed using STATA Version 14. Descriptive analysis such as propor-
tions for categorical variables and mean (median) for continuous variables were calculated.
Chi squared tests (χ2) were used to determine any crude association between categorical vari-
ables. Results were considered to indicate statistical significance, if a two-tailed p-value was
less than 0.05. Univariate and multivariable logistic regression models were used to estimate
unadjusted (ORs) and adjusted odds ratios (AORs) to identify variables related to the uptake
of maternal influenza and pertussis vaccines.
Human research ethics approval
The study protocol was approved by the Women’s and Children’s Health Network Human
Research Ethics Committee (HREC/14/WCHN/3).
Results
Participant’s characteristics
Of 300 pregnant women approached at the WCH, 205 women consented and completed the
antenatal survey questionnaire. Of the 205 participants, 24 were lost to follow up for the post-
natal interview and one participant was excluded from the study because of fetal death during
the pregnancy. Overall, 180 (88%) of the enrolled participants completed both the antenatal
survey and the postnatal follow-up telephone call questionnaire (Fig 1). Data analysis was per-
formed based on the 180 participants who completed both portions of the study.
The median age of participants was 31.1 years (range 21–43 years old), similar to the
median age (30.6 years) of South Australian pregnant women reported by Australian Bureau
of Statistics (ABS) in 2014 [29]. The majority of the pregnant women who participated in this
study were born in Australia (74%) (Table 1). These sample characteristics are similar to South
Australian for pregnant women according to the 2013 Pregnancy outcome SA report [30]. No
indigenous women particpated in this study. A total of 82 (46%) of the women were first time
mothers, while 54% of the participants were multiparous (Table 1).
Uptake of the recommended maternal vaccines
Pertussis. Almost all the participants (167/180, 93%) had heard of ‘pertussis’, regardless of
their immunization status. Of the 180 participants, 66% (n = 119) were aware of the recom-
mendation of pertussis vaccination during the 3rd trimester and 46% (n = 83) were aware that
they could receive a pertussis vaccination shortly after delivery if the vaccine was not given
during pregnancy. Overall, 82% (148/180) of the participants received pertussis vaccination;
81% (n = 145/180) during pregnancy and 2% (n = 3/180) post-delivery of their baby. Overall,
63% (92/145) of the women reported receiving the vaccine during pregnancy from a midwife
during their antenatal visit at WCH, 32% (47/145) from a general practitioner (GP), 3% (4/
145) from an occupational immunization provider and 1% from a community health center.
Women who had heard of the availability of maternal pertussis vaccination prior to study par-
ticipation had almost 8 times higher odds of receiving the vaccine during pregnancy (OR 7.8,
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CI 3.3–18.3; p<0.001) (Table 2). Almost all infants 97% (175/180) were vaccinated with the
routine diphtheria, tetanus and acellular pertussis (DTaP) vaccines (scheduled at 6–8 weeks of
age).
Fig 1. Recruitment flowchart.
https://doi.org/10.1371/journal.pone.0197867.g001
Table 1. Baseline characteristics of the study population.
Study population (n = 180)
Characteristics Level Total number Percentage
Maternal Age 18–31 96 53
32–41 84 47
Born in Australia Yes 116 74
No 42 26
Parity Primiparous 82 46
Multiparous 98 54
Pregnancy trimester (at the time of enrolment) 1st 17 9
2nd 62 34
3rd 101 56
NB: Country of birth missing data, n = 22.
https://doi.org/10.1371/journal.pone.0197867.t001
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Influenza. Overall, 80% (144/180) of the women who participated in this study received
influenza vaccination; 76% (n = 136) of the participants received influenza vaccination during
pregnancy and 5% (n = 8) received the vaccine post-delivery. Overall, 38% of the women
reported receiving the vaccine during pregnancy from a general practitioner (GP), 37% from a
midwife at WCH, 8% from occupational immunization provider, 1% from a community
health center and 16% of the women failed to report where they have received the vaccine. Of
the 180 study participants, 82% of them were aware that influenza vaccine is recommended
during pregnancy, 67% were aware that they could receive influenza vaccine at any stage of
their pregnancy and 65% of the women had discussed maternal influenza vaccination with
their health care providers (HCPs). Pregnant women who had received a recommendation
from their HCP had 3 times greater odds of receiving maternal influenza vaccination than
women who had not received a recommendation (Table 3). Of the 130 women who received
influenza vaccination during pregnancy (6 participants did not report their dates of vaccina-
tion), the majority (62%, 81/130) received the influenza vaccine in April (n = 47) or May
(n = 34). A further 45 women (35%) received the vaccine during the influenza season which is
typically between May to October in South Australia, with very few women (3%) being vacci-
nated between January and March. It should also be noted that influenza vaccine has generally
not been available between January and March prior to release of the new seasonal vaccine.
Among the most common reasons women cited for not receiving the vaccine during preg-
nancy were lack of recommendations from their HCPs (28%, n = 14) (Table 4).
Maternal vaccine uptakes pre-post introduction of a midwife delivered
immunization program at WCH in SA
Pertussis. The proportion of women who received pertussis vaccine during pregnancy
following the introduction of the midwife delivered vaccination program for pregnant women
was significantly higher (140/155, 90%) compared with women who delivered prior to the
introduction of the program (5/25, 20%; p<0.001) (Fig 2). The univariate odds of women













Maternal age category 21–31 85/96 (89%) 1.00 1.00
32–43 60/82 (73%) 0.35 0.18–0.78 0.010 0.39 0.130–
1.11
0.078
Country of birth Australia 102/116(88%) 1.00
Other 32/42(76%) 0.30 0.28–2.14 0.124
Parity Primiparous 70/82 (85%) 1.00
Multiparous 75/98 (77%) 0.53 0.24–1.18 0.116
Awareness of maternal pertussis
recommendation
No 37/64 (63%) 1.00 1.00
Yes 108/117(82%) 7.78 3.31–18.2 <0.001 4.43 1.61–
12.23
0.009
A midwife delivered maternal
immunization program








aAdjusted odds ratio comparing odds of receiving pertussis vaccine during pregnancy if offered, controlling for other variables.
bOnly univariate associations with p value <0.1 were included in the multivariable logistic regression.
https://doi.org/10.1371/journal.pone.0197867.t002
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receiving maternal pertussis vaccine following the implementation of the government funded
pertussis program and midwife delivered maternal immunization program in the antenatal
clinic of the WCH was almost 32 times higher than women who delivered babies prior to the
program (OR 31.73, CI 10.24–98.27; p<0.001) (Table 2).
Influenza. Women who had received pertussis vaccine during pregnancy were also more
likely to have both been recommended the influenza vaccine during their pregnancy (90% vs
66%; p<0.001) and been immunized against influenza during pregnancy (92% vs 49%,
p<0.001) compared to pregnant women who had not received pertussis vaccine. The univari-
ate odds of women receiving influenza vaccine following the implementation of the midwife
program was 8 times higher than women who have given birth prior to the program (OR 8.0,
CI 3.06–20.9; p<0.001) (Table 3).
Table 4. Reasons cited for not receiving maternal influenza vaccination.
Reasons cited for NOT receiving the influenza vaccination during pregnancy Number (n) Percentage %
It was not suggested/recommended to me 14 28%
Prior experience of an adverse reaction after being vaccinated 8 16%
I did not know that pregnant women should be vaccinated 8 16%
I was unsure of the benefits or effectiveness of the vaccine 5 10%
Never had time to receive the vaccine 3 6%
Received the vaccine earlier this year 3 6%
I was not pregnant during the flu season 3 6%
Prefer natural immunity 2 4%
Flu vaccine exacerbates my Asthma 2 4%
Prefer to receive the vaccine after the baby is born 2 4%
NB. Women were allowed to report >1 reason.
https://doi.org/10.1371/journal.pone.0197867.t004
Table 3. Factors potentially associated with influenza vaccine uptake during pregnancy.
Univariate binomial regression Multivariable binomial regression











Maternal age category 21–31 81/96 (84%) 1.00 1.00





Country of birth Australia 91/116 (78%) 1.00
Other 32/42 (76%) 0.50 0.16–
1.57
0.763
Parity Primiparous 69/82 (84%) 1.00





Provider recommendation received No 40/64 (63%) 1.00 1.00





A midwife delivered maternal
immunization program








a Adjusted odds ratio comparing odds of receiving influenza vaccine during pregnancy if offered, controlling for other variables.
b Only univariate associations with p value <0.1 were included in the multivariable logistic regression
https://doi.org/10.1371/journal.pone.0197867.t003
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Association between socio-demographic factors and maternal vaccination
rates
Maternal age. The median age of participating women was 31 years. Maternal age older
than 31 years was associated with lower uptake of maternal influenza and pertussis immuniza-
tions. The odds of older women (32–43 years) receiving maternal influenza vaccine was less
than half that of younger women (OR 0.36; CI 0.17–0.74; p = 0.005). In multivariable logistic
regression analysis, maternal age remained a strong predictor for the uptake of influenza vac-
cine during pregnancy (AOR 0.40; CI 0.17–0.92 p = 0.031) (Table 3). Similarly, the odds of
older women receiving maternal pertussis vaccine was less than half that of younger women
(OR 0.35; CI 0.18–0.78; p = 0.010). However, after adjusting for all independent variables, the
association between maternal age and pertussis vaccine uptake during pregnancy was no lon-
ger statistically significant (AOR 0.39 CI 0.130–1.11; p = 0.078) (Table 2).
Country of birth. The proportion of women vaccinated against influenza and pertussis
during pregnancy was not statistically significantly different between women who were born
Fig 2. Maternal receipt of pertussis and influenza vaccine pre-and post-implementation of a midwife delivered maternal immunization program at the WCH in
South Australia.
https://doi.org/10.1371/journal.pone.0197867.g002
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in Australia and women born overseas (78% vs 76%; p = 0.763) (88% vs 76%; p = 0.124)
(Tables 2 and 3).
Parity. In the univariate analysis, the odds of multiparous women having received mater-
nal influenza vaccine was less than half that of first time mothers (OR 0.42 CI 0.20–0.87;
p = 0.022). In multivariate analysis, the odds of mothers with previous children receiving
maternal influenza vaccine remained less than half that of women with no previous children
(AOR 0.43; 95% CI 0.19–0.99 p = 0.048) (Table 3). However, for pertussis vaccine uptake,
whilst the odds of multiparous women receiving the vaccine was lower compared to first time
mothers in a univariate analysis, this was not statistically significant (OR 0.53 CI 0.24–1.18;
p = 0.116) (Table 2).
Discussion
Our results showed high uptake of pertussis (81%) and influenza (76%) vaccines during preg-
nancy. The higher uptake of pertussis vaccine during pregnancy compared to influenza vac-
cine in our study could be because most women perceive influenza as a disease affecting the
mother, whereas they see pertussis as a threat to the infant and thus relatively more risky [31].
Uptake of maternal pertussis vaccine by women who delivered at the WCH prior to the gov-
ernment funded immunization programs was 20%, which significantly improved to 90% fol-
lowing the introduction of a midwife delivered and government funded pertussis program.
Similarly, the uptake of influenza vaccine during pregnancy has improved from 32% to 83%
following the implementation of a midwife delivered immunization program. National cover-
age for maternal pertussis vaccination programs in other countries is limited to local surveys
of vaccine coverage, for example an estimated coverage of over 60% was reported in the UK in
2016 [32], and 51% of women delivering during March 2014 in Wisconsin [33] while uptake
of 51–67% was reported in Argentina in 2014 [34].
The rise in vaccination rates could also be attributed to introduction of free pertussis vac-
cine for all pregnant women in South Australia in March 2015 [15]. The higher uptake of per-
tussis compared to influenza vaccine suggests pertussis vaccine uptake is driving influenza
vaccine uptake in pregnant women as the vaccines are co administered. Our results demon-
strate that the provision of maternal pertussis and influenza vaccination by midwives at the
place of antenatal service was an independent strong predictor of vaccination uptake during
pregnancy. It is a relatively low cost intervention, which has produced a significant increase on
vaccine uptake. Pregnant women view midwives as a trusted source of health information
[35]. A previous study suggested that administering maternal immunizations into standard
antenatal care through midwives could improve immunization uptake among pregnant
women [36].
Our study demonstrated that receiving a recommendation from a HCP was a strong predic-
tor for receipt of maternal influenza vaccine. Women who had not received influenza vaccine
during their pregnancy were less likely to have been offered influenza vaccines. About one-
quarter of the women who had not received the vaccines reported they had not received a rec-
ommendation to have influenza vaccine during pregnancy. This suggest there is room for
improvement for HCPs in discussing maternal vaccinations with pregnant women. Several
other studies suggested that a recommendation from a HCP is the most significant factor in
improving vaccination uptake during pregnancy [27, 37, 38].
Previously identified factors associated with poor uptake of vaccines in pregnancy include
lack of perceived benefit by pregnant women [22], concern about the safety of maternal vacci-
nation [39], lack of awareness of vaccine recommendation during pregnancy [40, 41] and
expectant mother’s attitudes toward immunization during pregnancy [42, 43]. In this study,
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maternal age and parity were associated with uptake of influenza vaccines during pregnancy.
Multiparous women were less likely to be vaccinated against the influenza during pregnancy
compared to first time mothers. A similar finding has been reported from a previous study in
South Australia [44]. Multiparous women are more likely to attend fewer antenatal visits than
first time mothers [45]. They also tend to have lower emotional attachment to their unborn
baby [46] and have been found to think less about the health of their fetus than first time moth-
ers [47]. This may describe why women who had been pregnant before were less likely to be
immunized against influenza vaccine during pregnancy. However, our findings have shown
that there is no influence of parity on pertussis vaccine uptake during pregnancy
Our study also demonstrated that older women were less likely to be vaccinated against
influenza during pregnancy. A previous study also suggested that older women are less likely
to seek antenatal health care [48]. This could explain why older women were less likely to be
vaccinated against influenza during pregnancy. Our study findings indicate the need for tai-
lored and targeted interventions for older multiparous women in maternal influenza vaccina-
tion campaigns. However, a study conducted in the Netherlands has found that influenza
vaccine uptake during pregnancy was higher among older and multiparous pregnant women
which is in contrast to our study findings [49]. Our study also indicates that there is no influ-
ence of age on pertussis vaccination coverage, which is in contradiction with previous studies
[44, 50]. Hence, further research is needed to explore if older multiparous women are more or
less likely to receive maternal influenza or pertussis vaccine compared with young first time
mothers.
The primary strength of our study sample is the inclusion of pregnant women prior to and
following the implementation of a midwife delivered pertussis immunization programs for
pregnant women. This enabled us to compare the antenatal vaccination uptake rates prior to
and following the introduction of midwife delivered maternal immunization program. This
study has also examined the intention of pregnant women to receive the recommended vac-
cines during or post pregnancy and uptake of these vaccines was verified by follow up tele-
phone interview with the mothers after delivery.
This study was subject to some limitations. The participants in this study were recruited
through a public hospital antenatal clinic. Thus, the study findings may not be a representative
of the overall population of pregnant women in South Australia. Our relatively small sample
size could also be a limitation to this study. Results from the vaccination coverage before the
government funded immunization programs are based on a very small sample size and this
could be a potential limitation of the study. The study sample also excluded non-English-
speaking women and no indigenous women participated in the study therefore our findings
may not be representative of culturally and linguistically diverse (CALD) and Aboriginal and
Torres Strait Islander women. Vaccine uptake among women who reported they had received
influenza and pertussis vaccination during their pregnancy was not verified through audit of
medical records. Our study has also a potential selection bias, as women who are more accept-
ing of vaccination may have been more likely to agree to participate in the survey. Another
limitation of the study is that the questionnaire did not capture primary language, ethnicity,
household income, educational level, working situation and marital status, which may also be
important variables in assessing factors related to vaccine uptake during pregnancy.
Conclusions
High uptake of influenza and pertussis vaccines during pregnancy can be attained with health
care provider recommendation and inclusion of maternal immunization as part of standard
antenatal care. A midwife delivered maternal immunization program is a promising approach
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to improve maternal vaccine uptakes by pregnant women. Additional studies are needed to
monitor and evaluate the impact of government funded pertussis programs for pregnant
women to ensure optimum protection for pregnant women and their infants.
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